Join the Uceris group to help and get support from people like you.
Uceris News
Budesonide Yields Durable Reduction in eGFR for IgA Nephropathy
MONDAY, Aug. 21, 2023 – For patients with immunoglobulin A (IgA) nephropathy, nine months of treatment with targeted-release formulation of budesonide (Nefecon) yields a greater reduction in...
Studies Explore Risks for Exposure to Antenatal Corticosteroids
WEDNESDAY, Aug. 9, 2023 – Exposure to antenatal corticosteroids is associated with serious infection in children and with increased short- and long-term adverse health outcomes, according to two...
FDA Approves Uceris (budesonide) Rectal Foam for Ulcerative Colitis
RALEIGH, N.C., October 8, 2014 – Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that the Food and Drug Administration (FDA) has granted final approval for Uceris (budesonide) rectal foam...
Ask a question
To post your own question to this support group, sign in or create an account.